Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Portfolio Pulse from Benzinga Neuro
Cathie Wood's Ark Invest made significant portfolio adjustments, selling $14.5M worth of Tesla shares and buying Palantir shares. The firm also traded shares of Teladoc Health, Twist Bioscience, Recursion Pharmaceuticals, and Intellia Therapeutics.
July 03, 2024 | 2:26 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ark Invest bought shares of Intellia Therapeutics for its ARKG ETF.
The acquisition of Intellia Therapeutics shares suggests a bullish sentiment towards the company's potential.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Ark Invest purchased 37,053 shares of Palantir worth $957,078, highlighting confidence in the AI sector.
The purchase of Palantir shares by Ark Invest indicates a bullish outlook on the company's potential in the AI sector.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Ark Invest bought shares of Recursion Pharmaceuticals for its ARKG ETF.
The purchase of Recursion Pharmaceuticals shares indicates a positive outlook on the company's future performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Ark Invest sold shares of Teladoc Health from its ARKF ETF.
The sale of Teladoc Health shares may indicate a lack of confidence in the company's short-term performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Ark Invest sold $14.5M worth of Tesla shares despite a 10.2% rally driven by strong Q2 delivery numbers.
The sale of Tesla shares by a prominent investor like Ark Invest could signal a short-term bearish sentiment, despite the recent rally.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Ark Invest sold shares of Twist Bioscience from its ARKG ETF.
The sale of Twist Bioscience shares could suggest a bearish outlook on the company's short-term prospects.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70